NOTE: To place order using Credit Card, P-Card, or Purchase Order – please choose kit size above and click “Add to cart” button. You can place order online without creating an account.
Transfection Reagent for Fibroblast Cells (Fibroblast Cell Lines and Primary Fibroblasts)
- Proprietary cationic lipid formulation
High transfection efficiency of small RNA (siRNA, shRNA, miRNA), mRNA, pDNA
Effective and robust intracellular delivery
Kit includes Transfection Enhancer reagent
Work in the presence of serum
A proven reagent for establishing stable fibroblast cell lines
Download PowerPoint presentation for Fibroblast cells transfection kit: [PPT]
Developed and manufactured by Altogen Biosystems
Reagent exhibits at least 85% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.
Transfection Protocol and MSDS:
Download Altogen Biosystems Fibroblasts Transfection Protocol: [PDF]
Download MSDS: [PDF]
Fibroblast Cell Lines and Primary Fibroblasts:
Fibroblasts maintain the structure of connective tissues by secreting precursors of the extracellular matrix, primarily a variety of fibers and the ground substance. Fibroblasts and related connective tissues sculpt the major portion of an organism. Fibroblasts are derived from primitive mesenchyme. Fibroblasts have a branched cytoplasm that surrounds a nucleus with one or two nucleoli. Fibroblasts can migrate slowly over substratum as individual cells (in contrast to epithelial cells). Fibroblasts can show dissimilar phenotypes in different anatomical locations. Active fibroblasts have rough abundant endoplasmic reticulum. Fibroblasts often align in parallel clusters when crowded. Unlike the epithelial cells lining the body structures, fibroblasts don’t form flat mono-layers and are not restricted to a basal lamina on one side.
Figure 1. siRNAs targeting Lamin A/C mRNA or non-silencing control siRNA were transfected into fibroblast cells following the recommended protocol. At 48 hours post-transfection the cells were analyzed by qRT-PCR for gene expression levels. 18S rRNA levels were used to normalize the Lamin A/C data. Values are normalized to untreated sample. Data are means ± SD (n=3).
Figure 2. Protein expression of Lamin A/C in Fibroblast cells. DNA plasmid expressing Lamin A/C or siRNA targeting Lamin A/C were transfected into Fibroblast cells following Altogen Biosystems transfection protocol. At 72 hours post-transfection the cells were analyzed by Western Blot for protein expression levels (normalized by total protein, 10 µg of total protein loaded per each well). Untreated cells used as a negative control.
Selected Fibroblast transfection kit citations:
- The American Journal of Pathology. 2011 179(4). Defective Myofibroblast Formation from Mesenchymal Stem Cells … Cieslik et al [PDF]
- Cancer Research. 2011 71(15):5144-53. Inhibition of miR-193a expression by… Iliopoulos et al [PDF]
- Circulation Research. 2010 15;107(8). Kruppel-like factor-4 transcriptionally regulates … Cowan et al [PDF]
- Mol Cell Biol. 2013 33(7). SCO2 induces p53-mediated apoptosis by Thr845 phosphorylation … Madan et al [PDF]
Altogen Biosystems provides preoptimized transfection products for life science research applications. Transfection protocols are optimized for individual cancer cell lines. Altogen Biosystems developed two types of in vivo delivery kits for animal research: Tissue-targeted reagents (delivery to liver, pancreas, and kidney tissues), and broad range in vivo delivery reagents (PEG-Liposome, Nanoparticle-based, Lipid-based, and Polymer-based kits). Advanced formulation of reagents and optimized transfection protocols provide efficient intracellular delivery of proteins, DNA, RNA, and any other negatively charged molecules in vitro and in vivo. Read more about transfection technology at Altogen’s Transfection Resource.
Altogen Labs Research Services:
Altogen Labs provides GLP-compliant contract research studies for pre-clinical research, IND applications, and drug development. Biology CRO services include: Xenograft models (30+), development of stable cell lines, ELISA assay development, cell-based and tissue targeted RNAi studies, safety pharm/tox assays, and other studies (visit AltogenLabs.com).
- 0.5 ml (Catalog #1755)
- 1.5 ml (Catalog #1756)
- 1.5 ml CRISPR (Catalog #2142)
- 8.0 ml (Catalog #1757)